In November 2021, Daiichi Sankyo was selected as a pharmaceutical sector constituent of the Dow Jones Sustainability Indices World Index (DJSI World), a leading global ESG index, for the fifth consecutive year since 2017. A survey of approximately 3,500 companies worldwide was conducted, and 322 companies (including 35 Japanese companies) were selected for inclusion in DJSI World. In addition, we have been selected for the 12th consecutive year for the DJSI Asia Pacific.

 We will continue to aim to realize our purpose of "contribute to the enrichment of quality of life around the world", to continuously improve our corporate value, and to become a company that is trusted by our stakeholders.